Physician

Samer Rida Kalakish, M.D.

According to 2025 Medicare claims, Samer Kalakish, M.D. (NPI: 1093999385) practices urology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Kalakish is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Kalakish's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,100 traditional Medicare patients, billed 24,193 HCPCS/CPT codes, and received $285,714 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,468 prescription claims across 498 beneficiaries totaling $217,217 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 74 claims. Open Payments data shows 44 records totaling $1,291. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $162,168 and ending at $217,217. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,627 to $684.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	881	9,935	$249,471
2016	972	10,557	$269,484
2017	1,068	17,859	$312,605
2018	841	13,967	$225,380
2019	875	17,550	$286,796
2020	1,103	20,866	$272,172
2021	1,263	25,135	$330,751
2022	1,219	25,450	$319,343
2023	1,218	19,749	$274,291
2024	1,100	24,193	$285,714

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	512	2,237	$162,168
2016	550	2,376	$169,142
2017	543	2,248	$196,240
2018	522	1,944	$148,025
2019	512	2,038	$136,111
2020	514	2,048	$124,276
2021	603	2,091	$163,675
2022	504	1,606	$111,034
2023	500	1,472	$71,987
2024	498	1,468	$217,217

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	32	$5,511
2016	N/R	56	$10,094
2017	N/R	34	$7,399
2018	N/R	45	$10,106
2019	11	85	$24,166
2020	N/R	67	$20,696
2021	N/R	66	$24,410
2022	N/R	96	$35,254
2023	N/R	92	$37,549
2024	N/R	74	$37,000

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	140	192	$85
76770	Complete ultrasound scan behind abdominal cavity	394	481	$66
84153	Psa (prostate specific antigen) measurement, total	362	505	$18
81003	Automated urinalysis test	235	370	$2
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	112	12,450	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	20	1,320	$19,403
Gemtesa	Vibegron	19	810	$12,622
Tamsulosin Hcl	Tamsulosin Hcl	327	24,348	$3,866
Finasteride	Finasteride	303	23,085	$3,633
Desmopressin Acetate	Desmopressin Acetate	18	1,020	$1,664

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	30	$28,925
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	30	$7,936
A4402	Lubricant, per ounce	N	N/R	14	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,291	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samer Rida Kalakish, M.D.?

Tedicare shows public-source Medicare data for Samer Rida Kalakish, M.D. (NPI 1093999385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samer Rida Kalakish, M.D. have ACO affiliation data?

Samer Rida Kalakish, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Samer Rida Kalakish, M.D.?

Samer Rida Kalakish, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Samer Rida Kalakish, M.D. have Open Payments data?

Samer Rida Kalakish, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.